References
Concha J, Norris B. Studies on renal vasomotion. British Journal of Pharmacology 34: 277–290, 1968
Fozard JR. Mechanism of hypotensive effect of ketanserin. Journal of Cardiovascular Pharmacology 4: 829–838, 1982
Kalkman HO, Harms YM, van Gelderen EM, Batink HD, Timmermans PBMWM, et al. Hypotensive activity of serotonin antagonists; correlation with α1-adrenoceptor and serotonin receptor blockade. Life Sciences 32: 1499–1505, 1983
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sciences 28: 1015–1022, 1981
McCall RB, Schuette MR. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin. Journal of Pharmacology and Experimental Therapeutics 228: 704–710, 1984
Van Nueten JM, Janssen PAJ, van Beek J, Xhonneux R, Verbeuren TJ, et al. Vascular effects of ketanserin (R41468), a novel antagonist of 5-HT2 serotonergic receptors. Journal of Pharmacology and Experimental Therapeutics 218: 217–230, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshioka, M., Machiko, M., Togashi, H. et al. Inhibitory Effect of Ketanserin on Sympathetic Nerve Activity in Rats. Drugs 36 (Suppl 1), 97–101 (1988). https://doi.org/10.2165/00003495-198800361-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00017